Study of an experimental drug for advanced cancer
Part of Cancer, Lungs & breathing, Skin clinical trials.
This trial tests an experimental drug called ITC-6146RO for people with advanced or metastatic cancer who have run out of standard treatment options. The drug is given to see if it can shrink tumors or slow cancer growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older (19 or older in Korea).
- Your cancer must have spread or cannot be removed with surgery.
- You have tried standard treatments and no other approved options are available for you.
- You must be well enough to carry out daily activities (ECOG score 0 or 1).
- You cannot have cancer that has spread to the brain or spinal cord.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral drug called ISM5939 for people with advanced or metastatic solid tumors. It aims to see if the drug is safe and helps shrink or control cancer when other treatments have stopped working.
This trial tests an experimental drug called IPN01203 for people with advanced solid tumors that have grown after prior immunotherapy. The goal is to see if the drug is safe and can shrink tumors.
This early-phase study tests whether REGN4336 is safe and how well it works, by itself or with REGN5678, in adults with advanced prostate cancer. It may help people whose cancer has continued to worsen despite standard prostate cancer medicines.
This study tests two new study drugs (TT-4 and TT-10) alone and together in people with certain advanced cancers that have not responded to standard treatments. The goal is to see if these drugs are safe and effective in shrinking tumors or slowing the cancer's growth.
This trial is testing an investigational drug called ITR-251 in people with advanced solid tumors that have progressed after standard treatments. The study aims to see if the drug is safe and effective, and it includes a part specifically for men with a certain type of prostate cancer.
This trial tests a new drug that targets a protein called MET found on some cancer cells. It may help people with certain advanced cancers that have not responded to other treatments.
Hear when a new Metastatic Castration-resistant Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.